The current price is in 5,62$, Editas Medicine Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are David Litvak (Director-Technical Operations), Harry R. Gill (Senior Vice President-Operations), James C. Mullen (Chairman, President & Chief Executive Officer), Lisa A. Michaels (Chief Medical Officer & Executive Vice President), Mark S. Shearman (Chief Scientific Officer & Executive VP), Michelle Robertson (Treasurer, Chief Financial & Accounting Officer), Noaman Akhtar (Senior Director-Clinical Operations) and its address is 11 HURLEY STREET, CAMBRIDGE, Massachusetts, 2141, United States.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 5,77$ moving between 5,59$ and 5,94$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
